Alberto Casellas - 15 Nov 2024 Form 4 Insider Report for Synchrony Financial (SYF)

Role
EVP, CEO--Health & Wellness
Signature
/s/ Danielle Do as attorney in fact
Issuer symbol
SYF
Transactions as of
15 Nov 2024
Net transactions value
+$14,426
Form type
4
Filing time
19 Nov 2024, 18:09:49 UTC
Previous filing
19 Aug 2024
Next filing
23 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYF Dividend Equivalent Unit Award $14,426 +222 +0.34% $64.98 64,824 15 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYF Phantom Stock Units Award $0 +1 +0.39% $0.000000 181 15 Nov 2024 Common Stock 1 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents dividend equivalent units accrued on November 15, 2024 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.
F2 The reported phantom stock units were acquired pursuant to a dividend reinvestment feature under the Synchrony Financial Deferred Compensation Plan (the "Deferred Compensation Plan") and are to be settled, in cash, six months following the Reporting Person's separation from service to the Company, subject to the requirements set forth in the Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of Synchrony Financial common stock.

Remarks:

EVP, CEO--Health & Wellness